Programmable transdermal delivery of nicotine in hairless guinea pigs using carbon nanotube membrane pumps

Journal of Pharmaceutical Sciences

Volumn 101, Issue 10, 2012, Pages 3823-3832

  Paudel, Kalpana S ^a,c   Wu, Ji ^b,e   Hinds, Bruce J ^b   Stinchcomb, Audra L ^a,d  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c South College School of Pharmacy   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^e GEORGIA SOUTHERN UNIVERSITY   (United States)

Author keywords

Controlled release; Diffusion; Drug transport; Epithelial delivery; Membrane transport

Indexed keywords

COTININE; NICOTINE PATCH; SINGLE WALLED NANOTUBE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; COUNSELING; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DIFFUSION; DRUG METABOLISM; ELECTRIC BATTERY; EXPERIMENTAL GUINEA PIG; FEMALE; IN VIVO STUDY; ION TRANSPORT; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; SMOKING CESSATION PROGRAM; VALIDATION PROCESS;

EID: 84865382902     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23240     Document Type: Article

References (46)

1. Wills S. 2005. Drugs of abuse. Pharmaceutical Press London UK.
2. Volkow ND, Li TK. 2004. Drug addiction: The neurobiology of behaviour gone awry. Nat Rev Neurosci 5:963-970.
3. Robbins TW, Everitt BJ. 1999. Drug addiction: Bad habits add up. Nature 398:567-570.
4. Mello NK, Stevens NS. 1996. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424.
5. Etter JF, Stapleton JA. 2006. Nicotine replacement therapy for long-term smoking cessation: A meta-analysis. Tob Control 15:280-285.
6. Hughes JR, Shiffman S, Callas P, Zhang J. 2003. A meta-analysis of the efficacy of over-the-counter, nicotine replacement. Tob Control 12:21-27.
7. Stead LF, Perera R, Mant D, Lancaster T. 2008. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 1 CD000146.
8. Silagy C, Stead L, Mant D, Fowler G. 2004. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 3 CD000146.
9. Silagy C, Mant D, Fowler G, Lodge M. 1994. Metaanalysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343:139-142.
10. Silagy C, Mant D, Fowler G, Lodge M. 1994. The effectiveness of nicotine replacement therapies in smoking cessation Lancet 343:139-142).
11. Fagerstrom KO. 1982. A comparison of psychological and pharmacological treatment in smoking cessation. J Behav Med 5:343-351.
12. Hall SM, Humfleet GL, Reus VI, Hartz D, Maude-Griffin R. 2002. Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry 59:930-936.
13. Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K. 2007. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control 16:I53-I59.
14. Borland R, Segan CJ, Livingston PM, Owen N. 2001. The effectiveness of callback counselling for smoking cessation: A randomized trial. Addiction 96:881-889.
15. Lichtenstein E, Glasgow RE, Lando HA, OssipKlein DJ, Boles SM. 1996. Telephone counseling for smoking cessation: Rationales and meta-analytic review of evidence. Health Educ Res 11:243-257.
16. Zhu SH, Anderson CM, Tedeschi GJ, Rosbrook B, Jonson CE, Byrd M, Guitierrez-Terrell E. 2002. Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med 347:1087-1093.
17. Zhu SH, Stretch V, Balabanis M, Rosbrook B, Sadler G, Pierce JP. 1996. Telephone counseling for smoking cessation: Effects of single-session and multiple-session interventions. J Consult Clin Psychol 64:202-211.
18. Prausnitz MR, Langer R. 2008. Transdermal drug delivery. Nat Biotech 26:1261-1268.
19. Barry BW. 2001. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101-114.
20. Brown L, Langer R. 1988. Transdermal delivery of drugs. Ann Rev Med 39:221-229.
21. Hummer G, Rasaiah JC, Noworyta JP. 2001. Water conduction through the hydrophobic channel of a carbon nanotube. Nature 414:188-190.
22. Hinds BJ, Chopra N, Rantell T, Andrews R, Gavalas V, Bachas LG. 2004. Aligned multiwalled carbon nanotube membranes. Science 303:62-65.
23. Majumder M, Chopra N, Andrews R, Hinds BJ. 2005. Nanoscale hydrodynamics: Enhanced flow in carbon nanotubes. Nature 438:44-44.
24. Holt JK, Park HG, Wang Y, Stadermann M, Artyukhin AB, Grigoropoulos CP, Noy A, Bakajin O. 2006. Fast mass transport through sub-2-nanometer carbon nanotubes. Science 312:1034-1037.
25. Wu J, Gerstandt K, Zhang H, Liu J, Hinds BJ. 2012. Electrophoretically induced aqueous flow through single-walled carbon nanotube membranes. Nat Nano 7:133-139.
26. Wu J, Gerstandt K, Majumder M, Zhan X, Hinds BJ. 2011. Highly efficient electroosmotic flow through functionalized carbon nanotube membranes. Nanoscale 3:3321-3328.
27. Wu J, Paudel KS, Strasinger C, Hammell D, Stinchcomb AL, Hinds BJ. 2010. Programmable transdermal drug delivery of nicotine using carbon nanotube membranes. Proc Natl Acad Sci 107:11698-11702.
28. Zeidenberg P, jaffe JH, Kanzler M, Levitt MD, Langone JJ, Van Vunakis H. 1977. Nicotine: Cotinine levels in blood during cessation of smoking. Compr Psychiatry 18:92-101.
29. Matsukura S, Sakamoto N, Seino Y, Tamada T, Matsuyama H, Muranaka H. 1979. Cotinine excretion and daily cigarette smoking in habituated smokers. Clin Pharmacol Ther 25:555-561.
30. Galeazzi RL, Daenens P, Gugger M. 1985. Steady-state concentration of cotinine as a measure of nicotine-intake by smokers. Eur J Clin Pharmacol 28:301-304.
31. Kasperson RE, Renn O, Slovic P, Brown HS, Emel J, Goble R, Kasperson JX, Ratick S. 1988. The social amplification of risk: A conceptual framework. Risk Analysis 8:177-187.
32. Rosa M, Pacific R, Altieri L, Pichini S, Ottaviani G, Zuccaro P. 1992. How the steady-state cotinine concentration in cigarette smokers is directly related to nicotine intake. Clin Pharmacol Ther 52:324-329.
33. Cognard E, Staub C. 2003. Determination of nicotine and its major metabolite cotinine in plasma or serum by gas chromatography-mass spectrometry using ion-trap detection. Clin Chem Lab Med 41:1599-1607.
34. Stolker AL, Niesing W, Hogendoorn EA, Bisoen Rambali A, Vleeming W. 2003. Determination of nicotine and cotinine in rat plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr A 1020:35-43.
35. McGovren JP, Lubawy WC, Kostenbauder HB. 1976. Uptake and metabolism of nicotine by the isolated perfused rabbit lung. J Pharmacol Exp Ther 199:198-207.
36. Levy D, Kost J, Meshulam Y, Langer R. 1989. Effect of ultrasound on transdermal drug delivery to rats and guinea-pigs. J Clin Invest 83:2074-2078.
37. Ranade VV, Cannon JB. 2011. Drug delivery systems. CRC Press Boca Raton FL.
38. Paudel KS, Nalluri BN, Hammell DC, Valiveti S, Kiptoo P, Hamad MO, Crooks PA, Stinchcomb AL. 2005. Transdermal delivery of naltrexone and its active metabolite 6-β-naltrexol in human skin in vitro and guinea pigs in vivo. J Pharm Sci 94:1965-1975.
39. Sun L, Crooks RM. 2000. Single carbon nanotube membranes: A well-defined model for studying mass transport through nanoporous materials. J Am Chem Soc 122:12340-12345.
40. Bahr JL, Yang J, Kosynkin DV, Bronikowski MJ, Smalley RE, Tour JM. 2001. Functionalization of carbon nanotubes by electrochemical reduction of aryl diazonium salts: A bucky paper electrode. J Am Chem Soc 123:6536-6542.
41. Shin HS, Kim JG, Shin YJ, Jee SH. 2002. Sensitive and simple method for the determination of nicotine and cotinine in human urine, plasma and saliva by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 769:177-183.
42. Murphy SE, Villalta P, Ho SW, von Weymarn LB. 2007. Analysis of [3', 3'-d(2)]-nicotine and [3', 3'-d(2)]-cotinine by capillary liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 857:1-8.
43. Shakleya DM, Huestis MA. 2009. Simultaneous and sensitive measurement of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877:3537-3542.
44. Baumann F, Regenthal R, Burgos-Guerrero IL, Hegerl U, Preiss R. 2010. Determination of nicotine and cotinine in human serum by means of LC/MS. J Chromatogr B Analyt Technol Biomed Life Sci 878:107-111.
45. Miller EI, Norris HR, Rollins DE, Tiffany ST, Wilkins DG. 2010. A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878:725-737.
46. Kyerematen GA, Morgan M, Warner G, Martin LF, Vesell ES. 1990. Metabolism of nicotine by hepatocytes. Biochem Pharmacol 40:1747-1756.